SARS-CoV-2 alpha variant: is it really more deadly? A population level observational study
View ORCID ProfileCandace Makeda Moore, View ORCID ProfileRuslan Sergienko, View ORCID ProfileRonen Arbel
doi: https://doi.org/10.1101/2021.08.17.21262167
Candace Makeda Moore
1Maximizing Health Outcomes Research Lab, Sapir College, Sderot, Israel
Ruslan Sergienko
2Department of Health Policy and Management, Ben-Gurion University of the Negev, Beer Sheva, Israel
Ronen Arbel
1Maximizing Health Outcomes Research Lab, Sapir College, Sderot, Israel

Article usage
Posted August 18, 2021.
SARS-CoV-2 alpha variant: is it really more deadly? A population level observational study
Candace Makeda Moore, Ruslan Sergienko, Ronen Arbel
medRxiv 2021.08.17.21262167; doi: https://doi.org/10.1101/2021.08.17.21262167
Subject Area
Subject Areas
- Addiction Medicine (215)
- Allergy and Immunology (495)
- Anesthesia (106)
- Cardiovascular Medicine (1093)
- Dermatology (141)
- Emergency Medicine (274)
- Epidemiology (9758)
- Gastroenterology (480)
- Genetic and Genomic Medicine (2304)
- Geriatric Medicine (222)
- Health Economics (462)
- Health Informatics (1554)
- Health Policy (732)
- Hematology (236)
- HIV/AIDS (501)
- Medical Education (236)
- Medical Ethics (67)
- Nephrology (257)
- Neurology (2140)
- Nursing (134)
- Nutrition (335)
- Oncology (1172)
- Ophthalmology (363)
- Orthopedics (128)
- Otolaryngology (220)
- Pain Medicine (145)
- Palliative Medicine (50)
- Pathology (309)
- Pediatrics (694)
- Primary Care Research (265)
- Public and Global Health (4648)
- Radiology and Imaging (775)
- Respiratory Medicine (623)
- Rheumatology (274)
- Sports Medicine (210)
- Surgery (250)
- Toxicology (43)
- Transplantation (120)
- Urology (94)